According to Sutro Biopharma's latest financial reports the company's current earnings (TTM) are -A$0.11 B. In 2023 the company made an earning of -A$97.27 M an increase over its 2022 earnings that were of -A$0.18 B.The earnings displayed on this page is the company's Pretax Income.